Farias-Eisner R, Cirisano FD, Grouse D, et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease. Gynecol Oncol 1994;53:55–58.

• PubMed
Farias-Eisner R, Cirisano FD, Grouse D, Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease. Gynecol Oncol 1994;53:55–58.)| false
• Search Google Scholar
• Export Citation

Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst Rev 2000;2000:CD002036.

• PubMed
Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst Rev 2000;2000:CD002036.)| false
• Search Google Scholar
• Export Citation

Hacker NF, Berek JS, Lagasse LD, et al. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 1984;63:155–162.

• PubMed
Hacker NF, Berek JS, Lagasse LD, Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 1984;63:155–162.)| false
• Search Google Scholar
• Export Citation

Burke TW, Levenback C, Coleman RL, et al. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995;57:215–220.

• PubMed
Burke TW, Levenback C, Coleman RL, Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995;57:215–220.)| false
• Search Google Scholar
• Export Citation

Hacker NF, van der Velden J. Conservative management of early vulvar cancer. Cancer 1993;71(4 Suppl):1673–1677.

• PubMed
Hacker NF, van der Velden J. Conservative management of early vulvar cancer. Cancer 1993;71(4 Suppl):1673–1677.)| false
• Search Google Scholar
• Export Citation

Morgan MA, Mikuta JJ. Surgical management of vulvar cancer. Semin Surg Oncol 1999;17:168–172.

• PubMed
Morgan MA, Mikuta JJ. Surgical management of vulvar cancer. Semin Surg Oncol 1999;17:168–172.)| false
• Search Google Scholar
• Export Citation

de Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma. The price of less radical surgery. Cancer 2002;95:2331–2338.

• PubMed
de Hullu JA, Hollema H, Lolkema S, Vulvar carcinoma. The price of less radical surgery. Cancer 2002;95:2331–2338.)| false
• Search Google Scholar
• Export Citation

Heaps JM, Fu YS, Montz FJ, et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990;38:309–314.

• PubMed
Heaps JM, Fu YS, Montz FJ, Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990;38:309–314.)| false
• Search Google Scholar
• Export Citation

Rouzier R, Haddad B, Plantier F, et al. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 2002;100:1159–1167.

• PubMed
Rouzier R, Haddad B, Plantier F, Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 2002;100:1159–1167.)| false
• Search Google Scholar
• Export Citation

Chan JK, Sugiyama V, Pham H, et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 2007;104:636–641.

• PubMed
Chan JK, Sugiyama V, Pham H, Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 2007;104:636–641.)| false
• Search Google Scholar
• Export Citation

DeSimone CP, Van Ness JS, Cooper AL, et al. The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus. Gynecol Oncol 2007;104:390–395.

• PubMed
DeSimone CP, Van Ness JS, Cooper AL, The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus. Gynecol Oncol 2007;104:390–395.)| false
• Search Google Scholar
• Export Citation

van der Velden J, Fons G, Lawrie TA. Primary groin irradiation versus primary groin surgery for early vulvar cancer. Cochrane Database Syst Rev 2011;2011:CD002224.

• PubMed
van der Velden J, Fons G, Lawrie TA. Primary groin irradiation versus primary groin surgery for early vulvar cancer. Cochrane Database Syst Rev 2011;2011:CD002224.)| false
• Search Google Scholar
• Export Citation

Stehman FB, Bundy BN, Thomas G, et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1992;24:389–396.

• PubMed
Stehman FB, Bundy BN, Thomas G, Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1992;24:389–396.)| false
• Search Google Scholar
• Export Citation

Hallak S, Ladi L, Sorbe B. Prophylactic inguinal-femoral irradiation as an alternative to primary lymphadenectomy in treatment of vulvar carcinoma. Int J Oncol 2007;31:1077–1085.

• PubMed
Hallak S, Ladi L, Sorbe B. Prophylactic inguinal-femoral irradiation as an alternative to primary lymphadenectomy in treatment of vulvar carcinoma. Int J Oncol 2007;31:1077–1085.)| false
• Search Google Scholar
• Export Citation

Petereit DG, Mehta MP, Buchler DA, et al. Inguinofemoral radiation of N0,N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation technique is used. Int J Radiat Oncol Biol Phys 1993;27:963–967.

• PubMed
Petereit DG, Mehta MP, Buchler DA, Inguinofemoral radiation of N0,N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation technique is used. Int J Radiat Oncol Biol Phys 1993;27:963–967.)| false
• Search Google Scholar
• Export Citation

Rouzier R, Haddad B, Atallah D, et al. Surgery for vulvar cancer. Clin Obstet Gynecol 2005;48:869–878.

• PubMed
Rouzier R, Haddad B, Atallah D, Surgery for vulvar cancer. Clin Obstet Gynecol 2005;48:869–878.)| false
• Search Google Scholar
• Export Citation

Stehman FB, Look KY. Carcinoma of the vulva. Obstet Gynecol 2006;107:719–733.

• PubMed
Stehman FB, Look KY. Carcinoma of the vulva. Obstet Gynecol 2006;107:719–733.)| false
• Search Google Scholar
• Export Citation

Magrina JF, Gonzalez-Bosquet J, Weaver AL, et al. Squamous cell carcinoma of the vulva stage IA: long-term results. Gynecol Oncol 2000;76:24–27.

• PubMed
Magrina JF, Gonzalez-Bosquet J, Weaver AL, Squamous cell carcinoma of the vulva stage IA: long-term results. Gynecol Oncol 2000;76:24–27.)| false
• Search Google Scholar
• Export Citation

Yoder BJ, Rufforny I, Massoll NA, et al. Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk. Am J Surg Pathol 2008;32:765–772.

• PubMed
Yoder BJ, Rufforny I, Massoll NA, Stage IA vulvar squamous cell carcinoma: an analysis of tumor invasive characteristics and risk. Am J Surg Pathol 2008;32:765–772.)| false
• Search Google Scholar
• Export Citation

Wilkinson EJ. Superficial invasive carcinoma of the vulva. Clin Obstet Gynecol 1985;28:188–195.

• PubMed
Wilkinson EJ. Superficial invasive carcinoma of the vulva. Clin Obstet Gynecol 1985;28:188–195.)| false
• Search Google Scholar
• Export Citation

Coleman RL, Ali S, Levenback CF, et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol 2013;128:155–159.

• PubMed
Coleman RL, Ali S, Levenback CF, Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol 2013;128:155–159.)| false
• Search Google Scholar
• Export Citation

Woelber L, Eulenburg C, Grimm D, et al. The risk of contralateral non-sentinel metastasis in patients with primary vulvar cancer and unilaterally positive sentinel node. Ann Surg Oncol 2016;23:2508–2514.

• PubMed
Woelber L, Eulenburg C, Grimm D, The risk of contralateral non-sentinel metastasis in patients with primary vulvar cancer and unilaterally positive sentinel node. Ann Surg Oncol 2016;23:2508–2514.)| false
• Search Google Scholar
• Export Citation

Van der Kolk WL, Van der Zee AG, Slomovitz BM, et al. Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe. Gynecol Oncol 2022;167:3–10.

• PubMed
Van der Kolk WL, Van der Zee AG, Slomovitz BM, Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe. Gynecol Oncol 2022;167:3–10.)| false
• Search Google Scholar
• Export Citation

Greer BE, Berek JS, eds. Current Topics In Obstetrics And Gynecology: Gynecologic Oncology: Treatment Rationale And Techniques. Elsevier; 1991.

• PubMed
Greer BE, Berek JS, eds. Current Topics In Obstetrics And Gynecology: Gynecologic Oncology: Treatment Rationale And Techniques. Elsevier; 1991.)| false
• Export Citation

Forner DM, Lampe B. Exenteration in the treatment of stage III/IV vulvar cancer. Gynecol Oncol 2012;124:87–91.

• PubMed
Forner DM, Lampe B. Exenteration in the treatment of stage III/IV vulvar cancer. Gynecol Oncol 2012;124:87–91.)| false
• Search Google Scholar
• Export Citation

Miller B, Morris M, Levenback C, et al. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol 1995;58:202–205.

• PubMed
Miller B, Morris M, Levenback C, Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol 1995;58:202–205.)| false
• Search Google Scholar
• Export Citation

Hoffman MS, Cavanagh D, Roberts WS, et al. Ultraradical surgery for advanced carcinoma of the vulva: an update. Int J Gynecol Cancer 1993;3:369–372.

• PubMed
Hoffman MS, Cavanagh D, Roberts WS, Ultraradical surgery for advanced carcinoma of the vulva: an update. Int J Gynecol Cancer 1993;3:369–372.)| false
• Search Google Scholar
• Export Citation

Gadducci A, Cionini L, Romanini A, et al. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol 2006;60:227–241.

• PubMed
Gadducci A, Cionini L, Romanini A, Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol 2006;60:227–241.)| false
• Search Google Scholar
• Export Citation

Boronow RC. Combined therapy as an alternative to exenteration for locally advanced vulvo-vaginal cancer: rationale and results. Cancer 1982;49:1085–1091.

• PubMed
Boronow RC. Combined therapy as an alternative to exenteration for locally advanced vulvo-vaginal cancer: rationale and results. Cancer 1982;49:1085–1091.)| false
• Search Google Scholar
• Export Citation

Fuh KC, Berek JS. Current management of vulvar cancer. Hematol Oncol Clin North Am 2012;26:45–62.

• PubMed
Fuh KC, Berek JS. Current management of vulvar cancer. Hematol Oncol Clin North Am 2012;26:45–62.)| false
• Search Google Scholar
• Export Citation

Leiserowitz GS, Russell AH, Kinney WK, et al. Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol Oncol 1997;66:509–514.

• PubMed
Leiserowitz GS, Russell AH, Kinney WK, Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol Oncol 1997;66:509–514.)| false
• Search Google Scholar
• Export Citation

Russell AH, Mesic JB, Scudder SA, et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol 1992;47:14–20.

• PubMed
Russell AH, Mesic JB, Scudder SA, Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol 1992;47:14–20.)| false
• Search Google Scholar
• Export Citation

Thomas G, Dembo A, DePetrillo A, et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 1989;34:263–267.

• PubMed
Thomas G, Dembo A, DePetrillo A, Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 1989;34:263–267.)| false
• Search Google Scholar
• Export Citation

Eifel PJ, Morris M, Burke TW, et al. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol 1995;59:51–56.

• PubMed
Eifel PJ, Morris M, Burke TW, Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol 1995;59:51–56.)| false
• Search Google Scholar
• Export Citation

Lupi G, Raspagliesi F, Zucali R, et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer 1996;77:1472–1478.

• PubMed
Lupi G, Raspagliesi F, Zucali R, Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer 1996;77:1472–1478.)| false
• Search Google Scholar
• Export Citation

Moore DH, Thomas GM, Montana GS, et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:79–85.

• PubMed
Moore DH, Thomas GM, Montana GS, Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 1998;42:79–85.)| false
• Search Google Scholar
• Export Citation

Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol 2006;100:53–57.

• PubMed
Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol 2006;100:53–57.)| false
• Search Google Scholar
• Export Citation

Landoni F, Maneo A, Zanetta G, et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol 1996;61:321–327.

• PubMed
Landoni F, Maneo A, Zanetta G, Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol 1996;61:321–327.)| false
• Search Google Scholar
• Export Citation

Berek JS, Heaps JM, Fu YS, et al. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 1991;42:197–201.

• PubMed
Berek JS, Heaps JM, Fu YS, Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol 1991;42:197–201.)| false
• Search Google Scholar
• Export Citation

Koh WJ, Wallace HJ 3rd, Greer BE, et al. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys 1993;26:809–816.

• PubMed
Koh WJ, Wallace HJ 3rd, Greer BE, Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys 1993;26:809–816.)| false
• Search Google Scholar
• Export Citation

Cunningham MJ, Goyer RP, Gibbons SK, et al. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol 1997;66:258–261.

• PubMed
Cunningham MJ, Goyer RP, Gibbons SK, Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol 1997;66:258–261.)| false
• Search Google Scholar
• Export Citation

Gerszten K, Selvaraj RN, Kelley J, et al. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol 2005;99:640–644.

• PubMed
Gerszten K, Selvaraj RN, Kelley J, Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol 2005;99:640–644.)| false
• Search Google Scholar
• Export Citation

Tans L, Ansink AC, van Rooij PH, et al. The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature. Am J Clin Oncol 2011;34:22–26.

• PubMed
Tans L, Ansink AC, van Rooij PH, The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature. Am J Clin Oncol 2011;34:22–26.)| false
• Search Google Scholar
• Export Citation

Han SC, Kim DH, Higgins SA, et al. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2000;47:1235–1244.

• PubMed
Han SC, Kim DH, Higgins SA, Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2000;47:1235–1244.)| false
• Search Google Scholar
• Export Citation

Rao YJ, Chin RI, Hui C, et al. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: a review of the National Cancer Database. Gynecol Oncol 2017;146:572–579.

• PubMed
Rao YJ, Chin RI, Hui C, Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: a review of the National Cancer Database. Gynecol Oncol 2017;146:572–579.)| false
• Search Google Scholar
• Export Citation

Montana GS, Thomas GM, Moore DH, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2000;48:1007–1013.

• PubMed
Montana GS, Thomas GM, Moore DH, Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 2000;48:1007–1013.)| false
• Search Google Scholar
• Export Citation

Moore DH, Ali S, Koh WJ, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol 2012;124:529–533.

• PubMed
Moore DH, Ali S, Koh WJ, A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol 2012;124:529–533.)| false
• Search Google Scholar
• Export Citation

van Triest B, Rasing M, van der Velden J, et al. Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: an efficacy study. Gynecol Oncol 2021;163:117–124.

• PubMed
van Triest B, Rasing M, van der Velden J, Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: an efficacy study. Gynecol Oncol 2021;163:117–124.)| false
• Search Google Scholar
• Export Citation

Natesan D, Hong JC, Foote J, et al. Primary versus preoperative radiation for locally advanced vulvar cancer. Int J Gynecol Cancer 2017;27:794–804.

• PubMed
Natesan D, Hong JC, Foote J, Primary versus preoperative radiation for locally advanced vulvar cancer. Int J Gynecol Cancer 2017;27:794–804.)| false
• Search Google Scholar
• Export Citation

Shylasree TS, Bryant A, Howells RE. Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev 2011;2011:CD003752.

• PubMed
Shylasree TS, Bryant A, Howells RE. Chemoradiation for advanced primary vulval cancer. Cochrane Database Syst Rev 2011;2011:CD003752.)| false
• Search Google Scholar
• Export Citation

van Doorn HC, Ansink A, Verhaar-Langereis M, et al. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev 2006;2006:CD003752.

• PubMed
van Doorn HC, Ansink A, Verhaar-Langereis M, Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev 2006;2006:CD003752.)| false
• Search Google Scholar
• Export Citation

Reade CJ, Eiriksson LR, Mackay H. Systemic therapy in squamous cell carcinoma of the vulva: current status and future directions. Gynecol Oncol 2014;132:780–789.

• PubMed
Reade CJ, Eiriksson LR, Mackay H. Systemic therapy in squamous cell carcinoma of the vulva: current status and future directions. Gynecol Oncol 2014;132:780–789.)| false
• Search Google Scholar
• Export Citation

Candelaria M, Garcia-Arias A, Cetina L, et al. Radiosensitizers in cervical cancer. Cisplatin and beyond. Radiat Oncol 2006;1:15.

• PubMed
Candelaria M, Garcia-Arias A, Cetina L, Radiosensitizers in cervical cancer. Cisplatin and beyond. Radiat Oncol 2006;1:15.)| false
• Search Google Scholar
• Export Citation

Lorvidhaya V, Chitapanarux I, Sangruchi S, et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial. Int J Radiat Oncol Biol Phys 2003;55:1226–1232.

• PubMed
Lorvidhaya V, Chitapanarux I, Sangruchi S, Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial. Int J Radiat Oncol Biol Phys 2003;55:1226–1232.)| false
• Search Google Scholar
• Export Citation

Cerrotta A, Gardan G, Cavina R, et al. Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose. Eur J Gynaecol Oncol 2002;23:115–119.

• PubMed
Cerrotta A, Gardan G, Cavina R, Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose. Eur J Gynaecol Oncol 2002;23:115–119.)| false
• Search Google Scholar
• Export Citation

Pattaranutaporn P, Thirapakawong C, Chansilpa Y, et al. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma. Gynecol Oncol 2001;81:404–407.

• PubMed
Pattaranutaporn P, Thirapakawong C, Chansilpa Y, Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma. Gynecol Oncol 2001;81:404–407.)| false
• Search Google Scholar
• Export Citation

Han SN, Vergote I, Amant F. Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer. Int J Gynecol Cancer 2012;22:865–868.

• PubMed
Han SN, Vergote I, Amant F. Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer. Int J Gynecol Cancer 2012;22:865–868.)| false
• Search Google Scholar
• Export Citation

Witteveen PO, van der Velden J, Vergote I, et al. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer—Gynaecological Cancer Group). Ann Oncol 2009;20:1511–1516.

• PubMed
Witteveen PO, van der Velden J, Vergote I, Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer—Gynaecological Cancer Group). Ann Oncol 2009;20:1511–1516.)| false
• Search Google Scholar
• Export Citation

Horowitz NS, Olawaiye AB, Borger DR, et al. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol 2012;127:141–146.

• PubMed
Horowitz NS, Olawaiye AB, Borger DR, Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol 2012;127:141–146.)| false
• Search Google Scholar
• Export Citation

Jolly S, Soni P, Gaffney DK, et al. ACR Appropriateness Criteria adjuvant therapy in vulvar cancer. Oncology (Williston Park) 2015;29:867–872; 874–865.

• PubMed
Jolly S, Soni P, Gaffney DK, ACR Appropriateness Criteria adjuvant therapy in vulvar cancer. Oncology (Williston Park) 2015;29:867–872; 874–865.)| false
• Search Google Scholar
• Export Citation

Homesley HD, Bundy BN, Sedlis A, et al. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986;68:733–740.

• PubMed
Homesley HD, Bundy BN, Sedlis A, Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986;68:733–740.)| false
• Search Google Scholar
• Export Citation

Kunos C, Simpkins F, Gibbons H, et al. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol 2009;114:537–546.

• PubMed
Kunos C, Simpkins F, Gibbons H, Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol 2009;114:537–546.)| false
• Search Google Scholar
• Export Citation

Swanick CW, Eifel PJ, Huo J, et al. Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer. Gynecol Oncol 2017;146:87–93.

• PubMed
Swanick CW, Eifel PJ, Huo J, Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer. Gynecol Oncol 2017;146:87–93.)| false
• Search Google Scholar
• Export Citation

Fons G, Groenen SM, Oonk MH, et al. Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol 2009;114:343–345.

• PubMed
Fons G, Groenen SM, Oonk MH, Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol 2009;114:343–345.)| false
• Search Google Scholar
• Export Citation

Mahner S, Jueckstock J, Hilpert F, et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 2015;107:dju426.

• PubMed
Mahner S, Jueckstock J, Hilpert F, Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 2015;107:dju426.)| false
• Search Google Scholar
• Export Citation

Parthasarathy A, Cheung MK, Osann K, et al. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol 2006;103:1095–1099.

• PubMed
Parthasarathy A, Cheung MK, Osann K, The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol 2006;103:1095–1099.)| false
• Search Google Scholar
• Export Citation

Woelber L, Eulenburg C, Choschzick M, et al. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer 2012;22:503–508.

• PubMed
Woelber L, Eulenburg C, Choschzick M, Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer 2012;22:503–508.)| false
• Search Google Scholar
• Export Citation

Gill BS, Bernard ME, Lin JF, et al. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis. Gynecol Oncol 2015;137:365–372.

• PubMed
Gill BS, Bernard ME, Lin JF, Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis. Gynecol Oncol 2015;137:365–372.)| false
• Search Google Scholar
• Export Citation

Swanick CW, Smith GL, Huo J, et al. Delivery and outcomes of adjuvant radiation therapy in older women with node-positive vulvar cancer. Oncology (Williston Park) 2016;30(Suppl 1):Abstract P021.

• PubMed
Swanick CW, Smith GL, Huo J, Delivery and outcomes of adjuvant radiation therapy in older women with node-positive vulvar cancer. Oncology (Williston Park) 2016;30(Suppl 1):Abstract P021.)| false
• Search Google Scholar
• Export Citation

Ignatov T, Eggemann H, Burger E, et al. Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol 2016;142:489–495.

• PubMed
Ignatov T, Eggemann H, Burger E, Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol 2016;142:489–495.)| false
• Search Google Scholar
• Export Citation

Viswanathan AN, Pinto AP, Schultz D, et al. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol 2013;130:545–549.

• PubMed
Viswanathan AN, Pinto AP, Schultz D, Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol 2013;130:545–549.)| false
• Search Google Scholar
• Export Citation

Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;26:884–889.

• PubMed
Van der Zee AG, Oonk MH, De Hullu JA, Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008;26:884–889.)| false
• Search Google Scholar
• Export Citation

van Beekhuizen HJ, Auzin M, van den Einden LC, et al. Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer. Int J Gynecol Cancer 2014;24:773–778.

• PubMed
van Beekhuizen HJ, Auzin M, van den Einden LC, Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer. Int J Gynecol Cancer 2014;24:773–778.)| false
• Search Google Scholar
• Export Citation

Bell JG, Lea JS, Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol 2000;77:314–318.

• PubMed
Bell JG, Lea JS, Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol 2000;77:314–318.)| false
• Search Google Scholar
• Export Citation

Stehman FB, Bundy BN, Dvoretsky PM, et al. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992;79:490–497.

• PubMed
Stehman FB, Bundy BN, Dvoretsky PM, Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992;79:490–497.)| false
• Search Google Scholar
• Export Citation

Kirby TO, Rocconi RP, Numnum TM, et al. Outcomes of stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol 2005;98:309–312.

• PubMed
Kirby TO, Rocconi RP, Numnum TM, Outcomes of stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol 2005;98:309–312.)| false
• Search Google Scholar
• Export Citation

Gonzalez Bosquet J, Magrina JF, Gaffey TA, et al. Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol 2005;97:828–833.

• PubMed
Gonzalez Bosquet J, Magrina JF, Gaffey TA, Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol 2005;97:828–833.)| false
• Search Google Scholar
• Export Citation

Nooij LS, van den Brand FA, Gaarenstroom KN, et al. Risk factors and treatment for recurrent vulvar squamous cell carcinoma. Crit Rev Oncol Hematol 2016;106:1–13.

• PubMed
Nooij LS, van den Brand FA, Gaarenstroom KN, Risk factors and treatment for recurrent vulvar squamous cell carcinoma. Crit Rev Oncol Hematol 2016;106:1–13.)| false
• Search Google Scholar
• Export Citation

Gien LT, Sutradhar R, Thomas G, et al. Patient, tumor, and health system factors affecting groin node dissection rates in vulvar carcinoma: a population-based cohort study. Gynecol Oncol 2015;139:465–470.

• PubMed
Gien LT, Sutradhar R, Thomas G, Patient, tumor, and health system factors affecting groin node dissection rates in vulvar carcinoma: a population-based cohort study. Gynecol Oncol 2015;139:465–470.)| false
• Search Google Scholar
• Export Citation

Salani R, Khanna N, Frimer M, et al. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecol Oncol 2017;146:3–10.

• PubMed
Salani R, Khanna N, Frimer M, An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecol Oncol 2017;146:3–10.)| false
• Search Google Scholar
• Export Citation

Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer 2000;89:116–122.

• PubMed
Maggino T, Landoni F, Sartori E, Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer 2000;89:116–122.)| false
• Search Google Scholar
• Export Citation

Mahner S, Prieske K, Grimm D, et al. Systemic treatment of vulvar cancer. Expert Rev Anticancer Ther 2015;15:629–637.

• PubMed
Mahner S, Prieske K, Grimm D, Systemic treatment of vulvar cancer. Expert Rev Anticancer Ther 2015;15:629–637.)| false
• Search Google Scholar
• Export Citation

Salom EM, Penalver M. Recurrent vulvar cancer. Curr Treat Options Oncol 2002;3:143–153.

• PubMed
Salom EM, Penalver M. Recurrent vulvar cancer. Curr Treat Options Oncol 2002;3:143–153.)| false
• Search Google Scholar
• Export Citation

Piura B, Masotina A, Murdoch J, et al. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 1993;48:189–195.

• PubMed
Piura B, Masotina A, Murdoch J, Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol 1993;48:189–195.)| false
• Search Google Scholar
• Export Citation

Raffetto N, Tombolini V, Santarelli M, et al. Radiotherapy alone and chemoirradiation in recurrent squamous cell carcinoma of the vulva. Anticancer Res 2003;23:3105–3108.

• PubMed
Raffetto N, Tombolini V, Santarelli M, Radiotherapy alone and chemoirradiation in recurrent squamous cell carcinoma of the vulva. Anticancer Res 2003;23:3105–3108.)| false
• Search Google Scholar
• Export Citation

Podratz KC, Symmonds RE, Taylor WF, et al. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 1983;61:63–74.

• PubMed
Podratz KC, Symmonds RE, Taylor WF, Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 1983;61:63–74.)| false
• Search Google Scholar
• Export Citation

Chiantera V, Rossi M, De Iaco P, et al. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. Int J Gynecol Cancer 2014;24:156–164.

• PubMed
Chiantera V, Rossi M, De Iaco P, Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. Int J Gynecol Cancer 2014;24:156–164.)| false
• Search Google Scholar
• Export Citation

Stehman FB, Bundy BN, Ball H, et al. Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1996;174:1128–1132; discussion 1132–1133.

• PubMed
Stehman FB, Bundy BN, Ball H, Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study. Am J Obstet Gynecol 1996;174:1128–1132; discussion 1132–1133.)| false
• Search Google Scholar
• Export Citation

Hopkins MP, Reid GC, Morley GW. The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol 1990;75:1001–1005.

• PubMed
Hopkins MP, Reid GC, Morley GW. The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol 1990;75:1001–1005.)| false
• Search Google Scholar
• Export Citation

Bellati F, Angioli R, Manci N, et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol 2005;96:227–231.

• PubMed
Bellati F, Angioli R, Manci N, Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol 2005;96:227–231.)| false
• Search Google Scholar
• Export Citation

Tewari KS, Sill MW, Penson RT, et al. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet 2017;390:1654–1663.

• PubMed
Tewari KS, Sill MW, Penson RT, Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet 2017;390:1654–1663.)| false
• Search Google Scholar
• Export Citation

Rosen VM, Guerra I, McCormack M, et al. Systematic review and network meta-analysis of bevacizumab plus first-line topotecan-paclitaxel or cisplatin-paclitaxel versus non-bevacizumab-containing therapies in persistent, recurrent, or metastatic cervical cancer. Int J Gynecol Cancer 2017;27:1237–1246.

• PubMed
Rosen VM, Guerra I, McCormack M, Systematic review and network meta-analysis of bevacizumab plus first-line topotecan-paclitaxel or cisplatin-paclitaxel versus non-bevacizumab-containing therapies in persistent, recurrent, or metastatic cervical cancer. Int J Gynecol Cancer 2017;27:1237–1246.)| false
• Search Google Scholar
• Export Citation

Kitagawa R, Katsumata N, Shibata T, et al. Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505. J Clin Oncol 2015;33:2129–2135.

• PubMed
Kitagawa R, Katsumata N, Shibata T, Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505. J Clin Oncol 2015;33:2129–2135.)| false
• Search Google Scholar
• Export Citation

Lorusso D, Petrelli F, Coinu A, et al. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol Oncol 2014;133:117–123.

• PubMed
Lorusso D, Petrelli F, Coinu A, A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol Oncol 2014;133:117–123.)| false
• Search Google Scholar
• Export Citation

Santeufemia DA, Capobianco G, Re GL, et al. Cisplatin-gemcitabine as palliative chemotherapy in advanced squamous vulvar carcinoma: report of two cases. Eur J Gynaecol Oncol 2012;33:421–422.

• PubMed
Santeufemia DA, Capobianco G, Re GL, Cisplatin-gemcitabine as palliative chemotherapy in advanced squamous vulvar carcinoma: report of two cases. Eur J Gynaecol Oncol 2012;33:421–422.)| false
• Search Google Scholar
• Export Citation

Monk BJ, Sill MW, McMeekin DS, et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009;27:4649–4655.

• PubMed
Monk BJ, Sill MW, McMeekin DS, Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009;27:4649–4655.)| false
• Search Google Scholar
• Export Citation

Migden MR, Rischin D, Schmults CD, et al. PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med 2018;379:341–351.

• PubMed
Migden MR, Rischin D, Schmults CD, PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med 2018;379:341–351.)| false
• Search Google Scholar
• Export Citation